Page last updated: 2024-11-05

ici 204,219 and Allergic Encephalomyelitis

ici 204,219 has been researched along with Allergic Encephalomyelitis in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Research Excerpts

ExcerptRelevanceReference
"In this study, we report that in experimental autoimmune encephalomyelitis animals, CysLT1 is upregulated in immune tissue and the spinal cord, and CysLT levels in the blood and cerebrospinal fluid are also higher than in normal mice."1.37Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis. ( Cui, Y; Du, C; Lv, J; Wang, L; Wei, W; Xie, X, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, L1
Du, C1
Lv, J1
Wei, W1
Cui, Y1
Xie, X1

Other Studies

1 other study available for ici 204,219 and Allergic Encephalomyelitis

ArticleYear
Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis.
    Journal of immunology (Baltimore, Md. : 1950), 2011, Sep-01, Volume: 187, Issue:5

    Topics: Acetates; Animals; Anti-Asthmatic Agents; Blood-Brain Barrier; Blotting, Western; Cell Separation; C

2011